Image: IANS

Covaxin booster can neutralise Omicron: Bharat Biotech

New Delhi | Covaxin’s booster dose is able to neutralise the vaccine evading Omicron variant of Covid-19, according to a study conducted at US’ Emory University, Bharat Biotech announced on Wednesday. Earlier studies have demonstrated the neutralising potential of Covaxin against other SARS-CoV-2 variants of concern such as Alpha, Beta, Delta, Zeta, and Kappa, it said. […]

𝗥𝗲𝗽𝗿𝗲𝘀𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗜𝗺𝗮𝗴𝗲 (𝗗𝗲𝗽𝗼𝘀𝗶𝘁 𝗣𝗵𝗼𝘁𝗼𝘀)

India’s first Intranasal Covid vaccine being developed by Bharat Biotech gets nod for Phase 2/3 trials

New Delhi | India’s first intranasal vaccine, being developed by Bharat Biotech in collaboration with the Department of Biotechnology and its PSU, the Biotechnology Industry Research Assistance Council (BIRAC), on Friday got regulatory approval for Phase 2/3 trials. “Bharat Biotech’s intranasal vaccine is the first nasal vaccine that has received the regulatory approval for Phase 2/3 […]

Representational Image | Freepik

Covaxin trials on children likely from next month

Hyderabad | Bharat Biotech may commence paediatric trials of its Covid-19 vaccine Covaxin from June, a senior company official said. The vaccine maker has already received permission to carry out trials on children aged 2-18 years. Bharat Biotech’s Business Development & International Advocacy Head, Dr Raches Ella, exuded confidence that vaccine for kids may get the […]

Image - IANS

Covaxin demonstrates protection against new variants

New Delhi | Peer-review publication, Clinical Infectious Diseases, has noted that Covaxin demonstrates protection against the new Covid-19 variants. Bharat Biotech’s Covaxin retained neutralising activity against emerging variants of coronavirus, as per a new study. A study published by Clinical Infectious Diseases found that vaccination with Covaxin produced neutralising titres against all key emerging variants tested […]